Supriya Lifescience Q4 Results
- BSE: 543434
- NSE: SUPRIYA
- ISIN: INE07RO01027
- Sector: Biotechnology & Drugs
BSE
900
-18.75 (-2.04%)
-18.75 (-2.04%)Volume16.14 K
Updated: Fri 11 Sep, 2026 | 15:25:17
NSE
904.40-13.05 (-1.42%)
-13.05 (-1.42%)Volume2.09 L
Updated: Fri 11 Sep, 2026 | 15:30:03
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q4 Results Highlights
Quarter ended Mar 26
Note: Comparison is on QoQ basis
Quarterly - Supriya Lifescience Q4 Results
*All figures in crores except per share values
| Fiscal Period | Mar 26 | Dec 25 | QoQ Comp | Mar 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 187.41 | 141.64 | 32.32% | 106.59 | 52.86% |
| Depreciation/ Amortization | 8.50 | 6.82 | 24.59% | 3.91 | 39.75% |
| Operating Income | 89.12 | 64.80 | 37.52% | 51.59 | 44.90% |
| Net Income | 74.23 | 49.68 | 49.43% | 36.93 | 47.34% |
| Other Operating Expenses Total | 48.77 | 48.46 | 0.63% | 27.27 | 19.76% |
| Net Income Before Taxes | 92.13 | 66.92 | 37.67% | 53.18 | 43.82% |
| Total Revenue | 276.53 | 206.44 | 33.95% | 158.18 | 50.20% |
| Selling/ General/ Admin Expenses Total | 24.82 | 24.69 | 0.50% | 17.14 | 18.31% |
| Diluted Normalized EPS | 9.22 | 6.21 | 48.42% | 4.59 | 46.67% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.